ICU Medical, Inc.

ICUI Healthcare Medical Instruments & Supplies

ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.

Revenue
+4.37%
EPS
+864.3%
Free cash flow
+292.2%
Total debt
−12.3%

Quarter to September 2026, against a year earlier

173.86 6.21 +3.70%
Market cap
$4.2B
P/E
69.3×
Fwd P/E
48.8×
Dividend yield
—
F-score
6/9
Altman Z
2.12
Beneish M
−2.65
Dividend safety
n/a

ICU Medical, Inc. (ICUI) Revenue

Alert me on Revenue

ICU Medical, Inc.'s revenue for fiscal 2025 was $2.2B, down 6.33% from $2.4B in fiscal 2024. Over the twelve months to 30 September 2026 it was $2.2B. Over the past ten years it has ranged from $341.7M (fiscal 2015) to $2.4B (fiscal 2024); the current reading is higher than 73% of that period. ICU Medical, Inc. ranks 18th of 47 Medical Instruments & Supplies companies by revenue.

Revenue, annual

Embed this chart

Annual newest first

Period Revenue Change
FY2025 $2.2B (6.33%)
FY2024 $2.4B 5.44%
FY2023 $2.3B (0.92%)
FY2022 $2.3B 73.21%
FY2021 $1.3B 3.56%
FY2020 $1.3B 0.38%
FY2019 $1.3B (9.56%)
FY2018 $1.4B 8.31%
FY2017 $1.3B 240.72%
FY2016 $379.4M 11.04%

Quarterly newest first

Period Revenue Change
Sep 2026 $560.4M 1.59%
Jun 2026 $551.7M 4.05%
Mar 2026 $530.2M (1.94%)
Dec 2025 $540.7M 0.69%
43 more quarters

Against its own ten years

Low $341.7M High $2.4B
Ten-year median $1.3B
Current reading's percentile 73

Revenue against peers

What Revenue is

Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.

Reported line item

The full definition of Revenue →

More on ICUI